<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Based on the presented data, NLC prepared with 
 <italic class="italic">Lavandula</italic> and 
 <italic class="italic">Rosmarinus</italic> (50 ng/mL) may be regarded as anti-proliferative agents and have potential to be used as co-adjuvants in the treatment of non-tumoral proliferative dermal diseases, such as infections, psoriasis, eczema, ichthyosis.
</p>
